Novacyt Explained

Novacyt S.A.
Traded As:
Foundation:2006
Location:Camberley, Surrey, United Kingdom
Key People:David Allmond (CEO)
Industry:Biotechnology
Products:In vitro and molecular diagnostics
Homepage:www.novacyt.com

Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France.[1] [2] The company produces in vitro and molecular diagnostic tests, supplying an extensive range assays and reagents worldwide.[3] Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.[4]

In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV.[5] [6] [7] [8] The test was approved as eligible for procurement under the World Health Organization's (WHO) Emergency Use Listing process in April 2020,[9] meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response.[10] In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory.[11] [12]

External links

Notes and References

  1. Web site: Offices . Novacyt . 1 February 2020.
  2. Web site: How dangerous is the coronavirus and how does it spread? . . 1 February 2020.
  3. Web site: Novacyt launches research-only Wuhan virus test . . 1 February 2020.
  4. Web site: Annual Report and Accounts for the year ended December 2018 . Novacyt . 1 February 2020.
  5. Web site: Healthcare Company Novacyt Launches New Coronavirus Test . . 1 February 2020.
  6. Web site: Novacyt shares jump 32% on launch of coronavirus test . . 1 February 2020.
  7. Web site: Chandlers Ford company Primerdesign launch novel coronavirus test . . 1 February 2020.
  8. Web site: Novacyt in prime position with coronavirus test . . 8 February 2020.
  9. Web site: WHO approves Novacyt's coronavirus testing kit . . 8 April 2020.
  10. Web site: WHO lists two COVID-19 tests for emergency use . . 10 April 2020.
  11. Web site: Novacyt's Covid-19 diagnostic test gets OK for WHO procurement . London South East . 8 April 2020.
  12. Web site: Novacyt joins AstraZeneca and GSK in UK effort on COVID-19 testing . . 8 April 2020.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Novacyt".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.